A Novel Homozygous Stop Mutation in IL23R Causes Mendelian Susceptibility to Mycobacterial Disease.


Journal

Journal of clinical immunology
ISSN: 1573-2592
Titre abrégé: J Clin Immunol
Pays: Netherlands
ID NLM: 8102137

Informations de publication

Date de publication:
11 2022
Historique:
received: 28 03 2022
accepted: 27 06 2022
pubmed: 14 7 2022
medline: 30 11 2022
entrez: 13 7 2022
Statut: ppublish

Résumé

Mendelian susceptibility to mycobacterial disease (MSMD) is caused by inborn errors of IFN-γ immunity. The most frequent genetic defects are found in IL12 or a subunit of its receptor. IL23R deficiency in MSMD has only been reported once, in two pediatric patients from the same kindred with isolated disseminated Bacille Calmette-Guérin disease. We evaluated the impact of a homozygous stop mutation in IL23R (R381X), identified by whole exome sequencing, in an adult patient with disseminated non-tuberculous mycobacterial disease. We performed functional validation of the R381X mutation by evaluating IL23R expression and IL-23 signaling (STAT3 phosphorylation, IFN-γ production) in primary cells (PBMCs, EBV-B cells) and cell lines (HeLa) with or without back-complementation of wild-type IL23R. We report on a 48-year-old male with disseminated non-tuberculous mycobacterial disease. We identified and characterized a homozygous loss-of-function stop mutation underlying IL23R deficiency, resulting in near absent expression of membrane bound IL23R. IL23R deficiency was characterized by impaired IL-23-mediated IFN-γ secretion in CD4 We demonstrate that impaired IL-23 immunity caused by a homozygous R381X mutation in IL23R underlies MSMD, corroborating earlier findings with a homozygous p.C115Y IL23R mutation. Our report further supports a model of redundant contribution of IL-23- to IL-17-mediated anti-fungal immunity.1.

Identifiants

pubmed: 35829840
doi: 10.1007/s10875-022-01320-7
pii: 10.1007/s10875-022-01320-7
pmc: PMC9700586
doi:

Substances chimiques

Interleukin-17 0
Nuclear Receptor Subfamily 1, Group F, Member 3 0
Interleukin-23 0
IL23R protein, human 0
Receptors, Interleukin 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1638-1652

Informations de copyright

© 2022. The Author(s).

Références

J Immunol. 2011 Nov 15;187(10):5402-7
pubmed: 22003199
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9560-5
pubmed: 21606346
Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):185-196
pubmed: 30478416
Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):
pubmed: 33876776
Clin Vaccine Immunol. 2012 Aug;19(8):1188-92
pubmed: 22695161
Ann Clin Microbiol Antimicrob. 2022 Mar 1;21(1):8
pubmed: 35232430
Lancet. 1995 Aug 26;346(8974):581
pubmed: 7658805
J Immunol. 2006 Dec 15;177(12):8684-92
pubmed: 17142769
Hum Genet. 2020 Jun;139(6-7):1001-1009
pubmed: 32055999
Sci Immunol. 2018 Dec 21;3(30):
pubmed: 30578351
Cell. 2020 Dec 23;183(7):1826-1847.e31
pubmed: 33296702
J Biol Chem. 2016 Apr 15;291(16):8673-85
pubmed: 26887945
Nat Immunol. 2009 Mar;10(3):314-24
pubmed: 19182808
Genes Immun. 2008 Oct;9(7):631-9
pubmed: 18754016
Immunol Cell Biol. 2019 Apr;97(4):360-367
pubmed: 30264912
J Exp Med. 2015 Jun 1;212(6):855-64
pubmed: 25941256
Bioinformatics. 2018 Dec 15;34(24):4307-4309
pubmed: 30535305
Hum Genet. 2020 Jun;139(6-7):993-1000
pubmed: 32025907

Auteurs

Frederik Staels (F)

Department of Microbiology, Immunology and Transplantation, Laboratory of Adaptive Immunology, KU Leuven, Leuven, Belgium.
Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, KU Leuven, Leuven, Belgium.

Flaminia Lorenzetti (F)

Department of Microbiology, Immunology and Transplantation, Laboratory of Adaptive Immunology, KU Leuven, Leuven, Belgium.
Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, KU Leuven, Leuven, Belgium.

Kerstin De Keukeleere (K)

Department of Microbiology, Immunology and Transplantation, Laboratory of Adaptive Immunology, KU Leuven, Leuven, Belgium.
Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, KU Leuven, Leuven, Belgium.

Mathijs Willemsen (M)

Department of Microbiology, Immunology and Transplantation, Laboratory of Adaptive Immunology, KU Leuven, Leuven, Belgium.
VIB Center for Brain and Disease Research, Leuven, Belgium.

Margaux Gerbaux (M)

Department of Microbiology, Immunology and Transplantation, Laboratory of Adaptive Immunology, KU Leuven, Leuven, Belgium.

Julika Neumann (J)

Department of Microbiology, Immunology and Transplantation, Laboratory of Adaptive Immunology, KU Leuven, Leuven, Belgium.
VIB Center for Brain and Disease Research, Leuven, Belgium.

Thomas Tousseyn (T)

Department of Imaging and Pathology, Laboratory for Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium.

Emanuela Pasciuto (E)

Department of Microbiology, Immunology and Transplantation, Laboratory of Adaptive Immunology, KU Leuven, Leuven, Belgium.
VIB Center for Brain and Disease Research, Leuven, Belgium.
Department of Neurosciences, Laboratory for the Research of Neurodegenerative Diseases, KU Leuven, Leuven, Belgium.

Paul De Munter (P)

Department of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium.

Xavier Bossuyt (X)

Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium.

Rik Gijsbers (R)

Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Viral Vector Technology and Gene Therapy, KU Leuven, Leuven, Belgium.
Leuven Viral Vector Core, KU Leuven, Leuven, Belgium.

Adrian Liston (A)

Department of Microbiology, Immunology and Transplantation, Laboratory of Adaptive Immunology, KU Leuven, Leuven, Belgium.
VIB Center for Brain and Disease Research, Leuven, Belgium.
Laboratory of Lymphocyte Signaling and Development, Babraham Institute, Cambridge, UK.

Stephanie Humblet-Baron (S)

Department of Microbiology, Immunology and Transplantation, Laboratory of Adaptive Immunology, KU Leuven, Leuven, Belgium.

Rik Schrijvers (R)

Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, KU Leuven, Leuven, Belgium. rik.schrijvers@uzleuven.be.
Department of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium. rik.schrijvers@uzleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH